National Center for Advancing and Translational Sciences Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences

Brody myopathy



Could you tell me in laymen's terms what is Brody disease?


What is Brody myopathy?

Brody myopathy is a hereditary condition that affects the skeletal muscles (muscles used for movement). Symptoms typically begin in childhood and are characterized by muscle cramping and stiffening (myopathy) after exercise or other strenuous activity. These symptoms can worsen in cold temperatures and are usually painless, however, some individuals may have mild discomfort.[1][2] Some cases of Brody myopathy are caused by mutations in the ATP2A1 gene. The cause of Brody myopathy for individuals not found to have an ATP2A1 gene mutation remains unknown. Brody myopathy is usually inherited in an autosomal recessive manner with a few reported cases of autosomal dominant inheritance.[1][2][3] While there is no one treatment for Brody myopathy, certain muscle relaxants, such as dantrolene and blood pressure medications called calcium channel blockers, such as verapamil may be useful.[3] 

Some researchers suggest that individuals found to have an ATP2A1 gene mutation have a slightly different disorder in which symptoms appear at an earlier age. They use the disease term "Brody disease" for individuals with an identified mutation versus "Brody syndrome" for those that do not.[1][4] More research may help clarify whether these are two different disorders or a variation of the same disorder.
Last updated: 7/29/2016

What are the symptoms of Brody myopathy?

Symptoms of Brody myopathy typically begin in childhood. Children with this condition may have a hard time keeping up with their peers in physical activities. They have a difficult time relaxing muscles, first in their arms and legs, but then in their face and trunk. They may also have difficulty relaxing their eyelids and grip. These muscle symptoms worsen with exercise and exposure to cold weather.[5]

In people with Brody myopathy, the term “pseudomyotonia” is used to describe these muscle symptoms. The term “myotonia” refers to muscle stiffness or an inability to relax the muscles and can be evidenced by abnormal electromyography (EMG) results. In Brody myopathy, the EMG results are normal, even though the person show signs of the muscle stiffness. Because of the normal EMG results, the word “pseudo-myotonia” is used.[5]

Individuals with Brody myopathy sometimes develop myoglobinuria. Myoglobinuria occurs when exercise leads to the breakdown of muscle tissue and release of a protein called myoglobin into the urine. Myoglobin causes the urine to be red or brown.[2]

Last updated: 8/3/2016

What causes Brody myopathy?

Brody myopathy can be caused by mutations in the gene ATP2A1 gene. This gene provides instructions for making an enzyme called sarco(endo)plasmic reticulum calcium-ATPase 1 (SERCA1). Enzymes are proteins that accelerate chemical reactions within the body. The SERCA1 enzyme is found in skeletal muscles (muscles used for movement). It is involved in moving calcium around in the cell, which is important for normal muscle contraction. Mutations in the ATP2A1 gene results in problems with calcium transportation in the cell, and ultimately problems with muscle contraction.[6]

Not all people with Brody myopathy have mutations in the ATP2A1 gene. There are likely other gene mutations, that have not yet been identified, that can cause this disease.[2]
Last updated: 8/3/2016

How is Brody myopathy inherited? 

Most cases of Brody myopathy are inherited in an autosomal recessive manner.[2] This means that to have the condition, a person must have a mutation in both copies of the responsible gene in each cell. People with Brody myopathy inherit one mutated copy of the gene from each parent, who is referred to as a carrier. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:
  • 25% (1 in 4) chance to be affected
  • 50% (1 in 2) chance to be an unaffected carrier like each parent
  • 25% (1 in 4) chance to be unaffected and not be a carrier
Last updated: 8/3/2016

How rare is Brody myopathy?

Brody myopathy is estimated to occur in 1 out of 10,000,000 people. Researchers suggest that this may be an underestimation as the diagnosis may go unrecognized.[1][7]
Last updated: 8/3/2016

How is Brody myopathy diagnosed?

Brody myopathy is suspected in people with the characteristic symptoms. The diagnosis may be confirmed using a combination of several different evaluations including:[5][1]
  • Physical examination
  • Bloodwork to evaluate the level of certain proteins such as creatine kinase
  • Muscle biopsy
  • Electromyography
Last updated: 8/3/2016

How might Brody myopathy be treated?

There is no one treatment for Brody myopathy. Certain muscle relaxants, such as dantrolene and blood pressure medications called calcium channel blockers, such as verapamil have been used with varying levels of success.[5][3]
Last updated: 8/3/2016

What is the long-term outlook for Brody myopathy? 

Symptoms of Brody myopathy may remain the same or slowly worsen with time. In advanced disease some people may experience some muscle loss (atrophy) and weakness.[5]
Last updated: 8/3/2016

We hope this information is helpful. We strongly recommend you discuss this information with your doctor. If you still have questions, please contact us.

Warm regards,
GARD Information Specialist

Please see our Disclaimer.


  1. Voermans NC, Laan AE, Oosterhof A, van Kuppevelt TH, Drost G, Lammens M, Kamsteeg EJ, Scotton C, Gualandi F, Guglielmi V, van den Heuvel L, Vattemi G, van Engelen BG. Brody syndrome: a clinically heterogeneous entity distinct from Brody disease: a review of literature and a cross-sectional clinical study in 17 patients. Neuromuscul Disord. Nov 2012; 22(11):944-954. http://www.ncbi.nlm.nih.gov/pubmed/22704959.
  2. Brody myopathy. Genetics Home Reference. January 2012; https://ghr.nlm.nih.gov/condition/brody-myopathy.
  3. Victor A. McKusick. Brody myopathy. In: Marla J. F. O'Neill. OMIM. 6/10/2011; http://www.omim.org/entry/601003.
  4. Guglielmi V, Vattemi G, Gualandi F, Voermans NC, Marini M, Scotton C, Pegoraro E, Oosterhof A, Kósa M, Zádor E, Valente EM, De Grandis D, Neri M, Codemo V, Novelli A, van Kuppevelt TH, Dallapiccola B, van Engelen BG, Ferlini A, Tomelleri G. SERCA1 protein expression in muscle of patients with Brody disease and Brody syndrome and in cultured human muscle fibers. Mol Genet Metab. 2013 Sep-Oct; 110(1-2):162-169. http://www.ncbi.nlm.nih.gov/pubmed/23911890.
  5. Rose M, Griggs RC. Hereditary Nondegernative Neuromuscular Disease. In: Goetz CG . Textbook of Clinical Neurology, 3rd ed. Philadelphia PA: Saunders; 2007;
  6. ATP2A1. Genetics Home Reference. January 2012; https://ghr.nlm.nih.gov/gene/ATP2A1.
  7. MacLennan DH. Ca2+ signalling and muscle disease. Eur J Biochem. Sep 2000; 267(17):5291-7. http://www.ncbi.nlm.nih.gov/pubmed/10951187.